Modes of the antibiotic activity of amphotericin B against Candida albicans

被引:0
|
作者
Ewa Grela
Agnieszka Zdybicka-Barabas
Bozena Pawlikowska-Pawlega
Malgorzata Cytrynska
Monika Wlodarczyk
Wojciech Grudzinski
Rafal Luchowski
Wieslaw I. Gruszecki
机构
[1] Institute of Physics,Department of Biophysics
[2] Maria Curie-Sklodowska University,Department of Plant Physiology and Biophysics
[3] Institute of Biological Sciences,Department of Immunobiology
[4] Faculty of Biology and Biotechnology,Department of Functional Anatomy and Cytobiology
[5] Maria Curie-Sklodowska University,undefined
[6] Institute of Biological Sciences,undefined
[7] Faculty of Biology and Biotechnology,undefined
[8] Maria Curie-Sklodowska University,undefined
[9] Institute of Biological Sciences,undefined
[10] Faculty of Biology and Biotechnology,undefined
[11] Maria Curie-Sklodowska University,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Amphotericin B is an antibiotic used as the “gold standard” in the treatment of life-threatening fungal infections. Several molecular mechanisms have been proposed to explain exceptionally high effectiveness of amphotericin B in combating fungi. In the present work, we apply fluorescence lifetime imaging microscopy to track, step by step, modes of the toxic activity of amphotericin B towards a clinical strain of Candida albicans. The images recorded reveal that the antibiotic binds to cells in the form of the small aggregates characterized by a relatively short fluorescence lifetime (0.2 ns). Amphotericin B binds preferentially to the cell walls of mature cells but also to the plasma membranes of the daughter cells at the budding stage. The images recorded with the application of a scanning electron microscopy show that the antibiotic interferes with the formation of functional cell walls of such young cells. The results of imaging reveal the formation of the amphotericin B-rich extramembranous structures and also binding of the drug molecules into the cell membranes and penetration into the cells. These two modes of action of amphotericin B are observed in the time scale of minutes.
引用
收藏
相关论文
共 50 条
  • [31] Amphotericin B-copper(II) complex as a potential agent with higher antifungal activity against Candida albicans
    Chudzik, Barbara
    Tracz, Izabela B.
    Czernel, Grzegorz
    Fiolka, Marta J.
    Borsuk, Grzegorz
    Gagos, Mariusz
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 49 (05) : 850 - 857
  • [32] ANTIFUNGAL ACTIVITY OF 4 TETRACYCLINE ANALOGS AGAINST CANDIDA-ALBICANS INVITRO - POTENTIATION BY AMPHOTERICIN-B
    LEW, MA
    BECKETT, KM
    LEVIN, MJ
    JOURNAL OF INFECTIOUS DISEASES, 1977, 136 (02): : 263 - 270
  • [33] Characterization of the inhibitory effect of voriconazole on the fungicidal activity of amphotericin B against Candida albicans in an in vitro kinetic model
    Lignell, Anders
    Loewdin, Elisabeth
    Cars, Otto
    Sjoelin, Jan
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (01) : 142 - 148
  • [34] A COMPARISON OF THE IN-VITRO ACTIVITY OF AMPHOTERICIN-B WITH THAT OF LIPOSOMAL AMPHOTERICIN-B AGAINST CANDIDA-ALBICANS COLONIZING CENTRAL VENOUS CATHETERS
    TEBBS, SE
    VEALE, EL
    ELLIOTT, TSJ
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1994, 34 (05) : 840 - 841
  • [35] Comparison of amphotericin B lipid complex, deoxycholate amphotericin B, fluconazole, and anidulafungin activity against Candida albicans biofilm isolated from breakthrough candidemia
    Kraft, Leticia
    Ribeiro, Victoria Stadler Tasca
    Goncalves, Geiziane Aparecida
    Suss, Paula Hansen
    Tuon, Felipe Francisco
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2023, 41 (10): : 596 - 603
  • [36] Interaction between posaconazole and amphotericin B in concomitant treatment against Candida albicans in vivo
    Cacciapuoti, A
    Gurnani, M
    Halpern, J
    Norris, C
    Patel, R
    Loebenberg, D
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (02) : 638 - 642
  • [37] IN-VITRO SENSITIVITY OF AMPHOTERICIN B, ITRACONAZOLE AND FLUCONAZOLE - RESISTANT AGAINST CANDIDA ALBICANS
    Singh, Desh Deepak
    Singh, Vinod
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2011, 2 (11): : 2964 - 2968
  • [38] AMPHOTERICIN B-RIFAMPIN SYNERGY AGAINST CANDIDA-ALBICANS AT THERAPEUTIC LEVELS
    BANNATYNE, RM
    CHEUNG, R
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1979, 25 (01): : 71 - 73
  • [39] Antimicrobial effect of amphotericin B electronically-activated water against Candida albicans
    Antonio Heredia-Rojas, J.
    Gomez-Flores, Ricardo
    Rodriguez-de la Fuente, Abraham O.
    Monreal-Cuevas, Enriqueta
    Cayetano Torres-Flores, Antonio
    Rodriguez-Flores, Laura E.
    Beltcheva, Michaela
    Cayetano Torres-Pantoja, Antonio
    AFRICAN JOURNAL OF MICROBIOLOGY RESEARCH, 2012, 6 (15): : 3684 - 3689
  • [40] Efficacy of caspofungin combined with amphotericin B against azole-resistant Candida albicans
    Hossain, MA
    Reyes, GH
    Long, LA
    Mukherjee, PK
    Ghannoum, MA
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (06) : 1427 - 1429